Alesi Surgical

Alesi Surgical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Alesi Surgical is a private, commercial-stage medical device company addressing the critical problem of surgical smoke in operating rooms. Its core innovation, the Ultravision system, utilizes electrostatic precipitation to eliminate smoke at the source, differentiating it from traditional evacuation systems. The company offers two main product lines: the Ultravision2 for laparoscopic surgery and the IonPencil for open surgery. It is positioned to capitalize on accelerating regulatory mandates in the U.S. and growing awareness of surgical smoke hazards globally.

Surgical Visualization & Safety

Technology Platform

Electrostatic precipitation (ESP) system for in-vivo elimination of surgical smoke. Comprises a generator and disposable/reusable components (Ionwand for laparoscopy, IonPencil for open surgery) that charge and capture smoke particles at the source.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

Accelerating legislative mandates in the U.S.
(over 20 states with enacted or pending laws) create a near-mandated market for compliant smoke management systems.
Growing global awareness of surgical smoke hazards post-pandemic and the clinical benefits of stable pneumoperitoneum and reduced CO2 exposure provide strong dual value propositions for hospital adoption.

Risk Factors

Facing competition from large, entrenched medtech companies with broader portfolios and stronger sales channels.
Commercial success depends on overcoming lengthy hospital procurement cycles and changing established surgical workflows.
Requires continuous capital for commercial scaling in a competitive market.

Competitive Landscape

Competes against traditional smoke evacuators (e.g., Stryker, CONMED, Buffalo Filter) that use suction/filtration, which Alesi claims are 23x less effective. Also competes with integrated filtration systems in laparoscopic insufflators. Key differentiation is Alesi's active elimination at source, CO2-sparing benefit, and ergonomic design (particularly the IonPencil).